HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells.

Abstract
The expression of CD34 antigen in acute myelogenous leukemias is considered an unfavourable prognosis marker for response to anticancer drugs and duration of remission. This study investigated the applicability of long-circulating immunoliposomes loaded with doxorubicin targeted to CD34 antigen present on MDR(+) human myelogenous leukemia KG-1a cell line. Immunoliposomal doxorubicin showed a higher cytotoxicity against KG-1a cells than non-targeted liposomal doxorubicin, but it did not improve over that of free drug. Although no reversal of doxorubicin resistance was found to occur through its liposomal encapsulation, a therapeutic benefit can be obtained by the selective cytotoxicity observed. Endocytosis studies demonstrated that, after binding to CD34 antigen, the immunoliposomes are not internalized by the KG-1a cells and so the cytotoxic effect might be due to drug released into the space near the cell membrane. Thus, immunotargeting of liposomal doxorubicin to CD34(+) leukemic cells may only provide an ex vivo strategy for site-selective CD34(+) leukemia cell killing.
AuthorsC Carrion, M A de Madariaga, J C Domingo
JournalLife sciences (Life Sci) Vol. 75 Issue 3 Pg. 313-28 (Jun 04 2004) ISSN: 0024-3205 [Print] Netherlands
PMID15135652 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Antibodies, Monoclonal
  • Antigens, CD34
  • Capsules
  • Drug Carriers
  • Liposomes
  • Doxorubicin
Topics
  • Antibiotics, Antineoplastic (administration & dosage, pharmacokinetics, pharmacology)
  • Antibodies, Monoclonal
  • Antigens, CD34 (immunology)
  • Capsules
  • Cell Division
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Chemistry, Pharmaceutical
  • Doxorubicin (administration & dosage, pharmacokinetics, pharmacology)
  • Drug Carriers
  • Drug Delivery Systems
  • Endocytosis (drug effects)
  • Flow Cytometry
  • Humans
  • Immunochemistry
  • Leukemia, Myeloid, Acute (drug therapy, pathology)
  • Liposomes
  • Microscopy, Confocal
  • Particle Size

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: